Mar. 8 at 2:58 PM
$AQST cont.
We Are Reiterating Today Our Commitment To Filing Our Resubmission In The Third Quarter Of This Year.
While It's Great To Have A Clear Path And Plan, You Also Need The Right Team, And I Am Fortunate That We Have A Fantastic Development Team Here At Aquestive, With The Recent Addition Of Dr. Matt Greenhawt, A World-Renowned Allergist And This Year's Recipient Of The Prestigious Distinguished Clinician Award By The American Academy Of Allergy, Asthma And Immunology, AAAAI, In Addition To Dr. Greenhawt Joining Us, We Are More Than Doubling The Size Of Our Medical Affairs Organization. This Will Allow Us To Attend More Conferences, Educate More Physicians On Our Data And Provide The Community With More Scientific Publications In The Coming Months.
We Also Will Be Meeting With The U.K. Health Authority, Known As MHRA, In The Coming Weeks. We Are Confident That Anaphylm Can Benefit All Humans, And We Want To Expand Access To Our Product Outside Of The U.S. As Rapidly As Possible.
